This week, as part of the France-Singapore Year of Innovation, Inserm welcomed two Singaporean delegations and took part in conferences on health topics identified as priorities by France and the city state.
In order to develop their strategic partnership and because innovation helps drive the transformation of our economies and societies, France and Singapore have decided to intensify their cooperation in matters of innovation. Hence 2018 being declared the France-Singapore Year of Innovation. The objective is to reinforce bilateral cooperation in the domain of innovation, and not just for this year.
France and Singapore have identified priority sectors to serve as a basis for showcasing innovation, bilateral initiatives and cooperation. Among these priority sectors, health, aging and the biotechnologies are central to the concerns and activities of Inserm.
A week of fruitful encounters
At the start of the week, Professor Yves Lévy had the honor of hosting Professor Low Teck Seng, President of the National Research Foundation, together with his delegation. They evoked potential future partnerships, particularly in the areas of artificial intelligence and metabolic diseases. The following day, Professor Lévy spoke at a round table organized by the French and Singaporean ministries of research, on the themes of biotechnologies and aging.
Claire Giry hosted a delegation from Singaporean Agency for Science Technology and Research (A*Star) which presented its international funding programs. While a number of cooperation themes were evoked, it would appear that health technologies are the most important to our Singaporean partners.
In addition, Inserm researchers Marina Cavazzana and Xavier Jouven participated in the Science, Policy, Society conference jointly held by Université Sorbonne Paris Cité and the National University of Singapore.